PMID- 34927212
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220204
IS  - 1869-6953 (Print)
IS  - 1869-6961 (Electronic)
IS  - 1869-6961 (Linking)
VI  - 13
IP  - 1
DP  - 2022 Jan
TI  - Are There Different Viewpoints About the Management of Type 2 Diabetes Mellitus 
      and Comorbidities? A Multidisciplinary Spanish Qualitative Research.
PG  - 189-203
LID - 10.1007/s13300-021-01188-7 [doi]
AB  - INTRODUCTION: The aim of this study was to explore the vision of a large 
      multidisciplinary group of physicians treating type 2 diabetes mellitus (T2DM) in 
      Spain, with a special focus on controversial management aspects. The perceptions 
      of primary care (PC) physicians and hospital care (HC) specialists were compared. 
      METHODS: This was a mixed survey that included Delphi-like statements and 
      opinion, attitude and behaviour (OAB) questions. The Delphi-like statements were 
      assessed on the basis of the degree of agreement among respondents, and a 
      descriptive analysis was performed on the answers to the OAB questions. RESULTS: 
      A total of 296 participants responded to the first wave of the survey, of whom 
      293 responded to the second wave (211 from PC and 80 from HC, with two 
      respondents for whom there were no data on specialty). A high degree of consensus 
      (CNS >/= 0.8) was obtained in all the statements. A proactive approach to detect 
      prediabetes or T2DM in asymptomatic people was highly supported (80.4% of 
      agreement). Introducing early treatment intensification was considered to favour 
      the durability of glycaemic control and to delay the progression of the disease 
      (80.4%). There was agreement on the statement that glycaemic variability 
      constitutes a risk factor for chronic complications, although differences in the 
      perceptions of HC physicians and PC specialists were identified (86.3 vs. 80.1%, 
      respectively). More HC physicans than PC specialists considered comorbidities to 
      affect the ability to self-care (95 vs. 82.9%, respectively). CONCLUSIONS: The 
      survey revealed that there was a high, albeit not universal, degree of agreement 
      amongst PC physicians and HC specialists in relation to prevention, screening and 
      diagnosis of T2DM; early treatment intensification; dysglycaemias; and the 
      management of patients with comorbidities. The statement on the management of 
      patients with comorbidities elicited the highest difference between PC physicans 
      and HC specialists. The results of this survey indicate that there is room for 
      improvement in terms of implementing strategies in these areas.
CI  - (c) 2021. The Author(s).
FAU - Cos, Francesc-Xavier
AU  - Cos FX
AUID- ORCID: 0000-0003-3943-479X
AD  - Medicina Familiar y Comunitaria, Fundacion Instituto Universitario para la 
      Investigacion en Atencion Primaria de Salud Jordi Gol i Gurina (IDIAPJGol), 
      Innovation Officer, Institut Catala de la Salut., Centro de Atencion Primaria 
      Sant Marti de Provencals, Barcelona, Spain.
FAU - Gomez-Huelgas, Ricardo
AU  - Gomez-Huelgas R
AUID- ORCID: 0000-0002-9909-3555
AD  - Servicio de Medicina Interna, Hospital Regional Universitario, Instituto de 
      Investigacion Biomedica de Malaga (IBIMA), Universidad de Malaga (UMA), Malaga, 
      CIBER Fisiopatologia de Obesidad y Nutricion (CIBERobn), Instituto de Salud 
      Carlos III, Madrid, Spain. ricardogomezhuelgas@hotmail.com.
FAU - Gomez-Peralta, Fernando
AU  - Gomez-Peralta F
AUID- ORCID: 0000-0003-0106-0091
AD  - Unidad de Endocrinologia y Nutricion, Hospital General de Segovia, Segovia, 
      Spain.
LA  - eng
PT  - Journal Article
DEP - 20211220
PL  - United States
TA  - Diabetes Ther
JT  - Diabetes therapy : research, treatment and education of diabetes and related 
      disorders
JID - 101539025
PMC - PMC8776935
OTO - NOTNLM
OT  - Antidiabetic agents
OT  - Clinical guidelines
OT  - Comorbidities
OT  - Diabetes Mellitus, type 2
OT  - Drug therapy, combination
OT  - Prediabetes
OT  - Primary care
OT  - Qualitative research
EDAT- 2021/12/21 06:00
MHDA- 2021/12/21 06:01
PMCR- 2021/12/20
CRDT- 2021/12/20 06:30
PHST- 2021/10/14 00:00 [received]
PHST- 2021/11/26 00:00 [accepted]
PHST- 2021/12/21 06:00 [pubmed]
PHST- 2021/12/21 06:01 [medline]
PHST- 2021/12/20 06:30 [entrez]
PHST- 2021/12/20 00:00 [pmc-release]
AID - 10.1007/s13300-021-01188-7 [pii]
AID - 1188 [pii]
AID - 10.1007/s13300-021-01188-7 [doi]
PST - ppublish
SO  - Diabetes Ther. 2022 Jan;13(1):189-203. doi: 10.1007/s13300-021-01188-7. Epub 2021 
      Dec 20.